Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
6 NC counties are under alert, including Johnston County.
Program
On WRAL after the DNC: Coolest August night in years. Where it will be below 60 when you wake up
Program
Thursday at 6 on WRAL: School bus safety: After years of mechanical issues, including fires â whatâs being done this year to prevent a disaster?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Certara Inc
(NQ:
CERT
)
12.90
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Certara Inc
< Previous
1
2
Next >
Certara to Participate in Upcoming Investor Conferences
August 21, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024
From
Certara
Via
GlobeNewswire
Certara Reports Second Quarter 2024 Financial Results
August 06, 2024
Reiterates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024
From
Certara
Via
GlobeNewswire
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
June 17, 2024
AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies
From
Certara
Via
GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024
From
Certara
Via
GlobeNewswire
Certara Reports First Quarter 2024 Financial Results
May 07, 2024
Reiterates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
April 16, 2024
From
Certara
Via
GlobeNewswire
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
April 09, 2024
From
Certara
Via
GlobeNewswire
Certara Reports Fourth Quarter 2023 Financial Results
February 29, 2024
Provides Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
February 01, 2024
From
Certara
Via
GlobeNewswire
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
December 13, 2023
Combined organization establishes the life sciences industry’s largest quantitative systems pharmacology (QSP) center of excellence contributing to faster and more effective medicine development.
From
Certara
Via
GlobeNewswire
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
November 21, 2023
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
From
Certara
Via
GlobeNewswire
Certara Reports Third Quarter 2023 Financial Results
November 08, 2023
Reiterates Full Year 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
October 11, 2023
From
Certara
Via
GlobeNewswire
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
September 19, 2023
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelines
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
August 29, 2023
From
Certara
Via
GlobeNewswire
Certara Simcyp™ Group Awarded Two New Grants from US FDA
August 29, 2023
Programs focus on use of physiologically-based pharmacokinetic (PBPK) modeling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations
From
Certara
Via
GlobeNewswire
Certara Reports Second Quarter 2023 Financial Results
August 09, 2023
Provides Update to Full Year 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
July 13, 2023
From
Certara
Via
GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
June 02, 2023
From
Certara
Via
GlobeNewswire
Certara Reports First Quarter 2023 Financial Results
May 08, 2023
Reiterates 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
April 27, 2023
Asserts Certara’s leadership in advancing the development and approval of new drugs for patients
From
Certara
Via
GlobeNewswire
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
April 10, 2023
From
Certara
Via
GlobeNewswire
Are These 3 Small Momentum Stocks Setting Up Big Gains?
March 22, 2023
MINISO, PDF Solutions, and Certara are small stocks with strong price momentum. It’s not unusual for small stocks to show more price momentum than larger peers.
Via
MarketBeat
A.I. Coming to Certara’s D360 Scientific Informatics Software
March 09, 2023
New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses.
From
Certara
Via
GlobeNewswire
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
March 07, 2023
Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies
From
Certara
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.